|
|
|
|
Дата |
|---|
| 04.06.2026 |
| 03.06.2026 |
| 02.06.2026 |
| 01.06.2026 |
| 25.05.2026 |
| 24.05.2026 |
| 21.05.2026 |
| 20.05.2026 |
| 19.05.2026 |
| 18.05.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
86.86
|
86.50
|
88.20
|
88.00
|
|
|
63 926 906.37
|
612.00
|
|
|
|
86.92
|
85.55
|
87.30
|
86.86
|
|
|
8 497 648.93
|
379.00
|
|
|
|
86.50
|
85.50
|
87.40
|
86.92
|
|
|
41 407 291.04
|
468.00
|
|
|
|
84.33
|
84.50
|
87.80
|
86.50
|
|
|
175 809 076.34
|
840.00
|
|
|
|
84.61
|
83.96
|
85.48
|
84.33
|
|
|
28 370 660.02
|
645.00
|
|
|
|
84.80
|
84.15
|
86.00
|
84.61
|
|
|
16 198 285.99
|
716.00
|
|
|
|
84.70
|
84.00
|
85.90
|
84.80
|
|
|
8 936 398.65
|
584.00
|
|
|
|
86.96
|
84.50
|
87.72
|
84.70
|
|
|
15 799 188.48
|
758.00
|
|
|
|
86.25
|
86.00
|
87.13
|
86.96
|
|
|
26 967 887.37
|
461.00
|
|
|
|
89.67
|
86.22
|
89.46
|
86.25
|
|
|
11 067 182.23
|
708.00
|
Период |
|---|
| 2025, регулярные |
| 2022, регулярные |
| 2020, регулярные |
| 2018, регулярные |
| 2017, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2012, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
26.04.2026
|
27.04.2026 |
3.5 EGP |
|
13.04.2023
|
18.04.2023 |
2 EGP |
|
21.04.2021
|
25.04.2021 |
2.95 EGP |
|
02.05.2019
|
05.05.2019 |
4 EGP |
|
06.04.2018
|
10.04.2018 |
4.5 EGP |
|
08.05.2017
|
09.05.2017 |
3.5 EGP |
|
21.04.2016
|
24.04.2016 |
3.5 EGP |
|
23.04.2013
|
24.04.2013 |
3 EGP |
|
24.05.2012
|
27.05.2012 |
3 EGP |
|
29.04.2011
|
02.05.2011 |
2.5 EGP |
Egyptian International Pharmaceuticals Industries Co SAE (EIPICO) is an Egypt-based public shareholding company that operates in the pharmaceuticals industry. The Company is a manufacturer and exporter of pharmaceuticals, and holds license agreements with a group of international pharmaceutical companies to produce their products locally and replace the imported ones. The Company produces dosage forms, such as spansule capsules (long-acting), as well as non-traditional dosage forms, such as the soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets
